search
Back to results

Acetyl-L-Carnitine Reduces Perceived Work Stress and Improves Work Ability and Work Performance in Hepatic Encephalopathy

Primary Purpose

Work Stress, Work Ability, Work Performance

Status
Completed
Phase
Phase 3
Locations
Italy
Study Type
Interventional
Intervention
Acetyl-L-carnitine
Placebo
Sponsored by
University of Catania
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Work Stress

Eligibility Criteria

33 Years - 68 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • overt hepatic encephalopathy (HE) or a history of overt HE

Exclusion Criteria:

  • history of recent alcohol intake; infection; recent antibiotic use or gastrointestinal bleeding; history of recent use of drugs affecting psychometric performances like benzodiazepines, antiepileptics or psychotropic drugs; a history of shunt surgery or transjugular intrahepatic portosystemic shunt for portal hypertension; electrolyte imbalance; renal impairment; hepatocellular carcinoma; severe medical problems such as congestive heart failure, pulmonary disease or neurological or psychiatric disorder that could influence quality of life measurement; inability to perform neuropsycological tests.

Sites / Locations

  • University of Catania

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

acetyl-L-carnitine

sugar pill

Arm Description

2 g acetyl-L carnitine twice a day for 90 days

Placebo twice a day for 90 days

Outcomes

Primary Outcome Measures

work stress

Secondary Outcome Measures

Full Information

First Posted
June 23, 2014
Last Updated
June 23, 2014
Sponsor
University of Catania
search

1. Study Identification

Unique Protocol Identification Number
NCT02173132
Brief Title
Acetyl-L-Carnitine Reduces Perceived Work Stress and Improves Work Ability and Work Performance in Hepatic Encephalopathy
Study Type
Interventional

2. Study Status

Record Verification Date
June 2014
Overall Recruitment Status
Completed
Study Start Date
April 2010 (undefined)
Primary Completion Date
November 2013 (Actual)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Catania

4. Oversight

5. Study Description

Brief Summary
This study evaluated the effects of acetyl-L-carnitine treatment on Perceived Work Stress, Work Ability and Work Performance in subjects with Hepatic Encephalopathy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Work Stress, Work Ability, Work Performance

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
94 (Actual)

8. Arms, Groups, and Interventions

Arm Title
acetyl-L-carnitine
Arm Type
Active Comparator
Arm Description
2 g acetyl-L carnitine twice a day for 90 days
Arm Title
sugar pill
Arm Type
Placebo Comparator
Arm Description
Placebo twice a day for 90 days
Intervention Type
Drug
Intervention Name(s)
Acetyl-L-carnitine
Intervention Type
Other
Intervention Name(s)
Placebo
Primary Outcome Measure Information:
Title
work stress
Time Frame
90 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
33 Years
Maximum Age & Unit of Time
68 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: overt hepatic encephalopathy (HE) or a history of overt HE Exclusion Criteria: history of recent alcohol intake; infection; recent antibiotic use or gastrointestinal bleeding; history of recent use of drugs affecting psychometric performances like benzodiazepines, antiepileptics or psychotropic drugs; a history of shunt surgery or transjugular intrahepatic portosystemic shunt for portal hypertension; electrolyte imbalance; renal impairment; hepatocellular carcinoma; severe medical problems such as congestive heart failure, pulmonary disease or neurological or psychiatric disorder that could influence quality of life measurement; inability to perform neuropsycological tests.
Facility Information:
Facility Name
University of Catania
City
Catania
ZIP/Postal Code
95126
Country
Italy

12. IPD Sharing Statement

Learn more about this trial

Acetyl-L-Carnitine Reduces Perceived Work Stress and Improves Work Ability and Work Performance in Hepatic Encephalopathy

We'll reach out to this number within 24 hrs